Noel J Leigh1, Ralph I Lawton1, Pamela A Hershberger2, Maciej L Goniewicz1. 1. Department of Health Behavior, Roswell Park Cancer Institute, Buffalo, New York, USA. 2. Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, New York, USA.
Abstract
BACKGROUND: E-cigarettes or electronic nicotine delivery systems (ENDS) are designed to deliver nicotine-containing aerosol via inhalation. Little is known about the health effects of flavoured ENDS aerosol when inhaled. METHODS: Aerosol from ENDS was generated using a smoking machine. Various types of ENDS devices or a tank system prefilled with liquids of different flavours, nicotine carrier, variable nicotine concentrations and with modified battery output voltage were tested. A convenience sample of commercial fluids with flavour names of tobacco, piña colada, menthol, coffee and strawberry were used. Flavouring chemicals were identified using gas chromatography/mass spectrometry. H292 human bronchial epithelial cells were directly exposed to 55 puffs of freshly generated ENDS aerosol, tobacco smoke or air (controls) using an air-liquid interface system and the Health Canada intense smoking protocol. The following in vitro toxicological effects were assessed: (1) cell viability, (2) metabolic activity and (3) release of inflammatory mediators (cytokines). RESULTS: Exposure to ENDS aerosol resulted in decreased metabolic activity and cell viability and increased release of interleukin (IL)-1β, IL-6, IL-10, CXCL1, CXCL2 and CXCL10 compared to air controls. Cell viability and metabolic activity were more adversely affected by conventional cigarettes than most tested ENDS products. Product type, battery output voltage and flavours significantly affected toxicity of ENDS aerosol, with a strawberry-flavoured product being the most cytotoxic. CONCLUSIONS: Our data suggest that characteristics of ENDS products, including flavours, may induce inhalation toxicity. Therefore, ENDS users should use the products with caution until more comprehensive studies are performed. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
BACKGROUND: E-cigarettes or electronic nicotine delivery systems (ENDS) are designed to deliver nicotine-containing aerosol via inhalation. Little is known about the health effects of flavoured ENDS aerosol when inhaled. METHODS: Aerosol from ENDS was generated using a smoking machine. Various types of ENDS devices or a tank system prefilled with liquids of different flavours, nicotine carrier, variable nicotine concentrations and with modified battery output voltage were tested. A convenience sample of commercial fluids with flavour names of tobacco, piña colada, menthol, coffee and strawberry were used. Flavouring chemicals were identified using gas chromatography/mass spectrometry. H292human bronchial epithelial cells were directly exposed to 55 puffs of freshly generated ENDS aerosol, tobacco smoke or air (controls) using an air-liquid interface system and the Health Canada intense smoking protocol. The following in vitro toxicological effects were assessed: (1) cell viability, (2) metabolic activity and (3) release of inflammatory mediators (cytokines). RESULTS: Exposure to ENDS aerosol resulted in decreased metabolic activity and cell viability and increased release of interleukin (IL)-1β, IL-6, IL-10, CXCL1, CXCL2 and CXCL10 compared to air controls. Cell viability and metabolic activity were more adversely affected by conventional cigarettes than most tested ENDS products. Product type, battery output voltage and flavours significantly affected toxicity of ENDS aerosol, with a strawberry-flavoured product being the most cytotoxic. CONCLUSIONS: Our data suggest that characteristics of ENDS products, including flavours, may induce inhalation toxicity. Therefore, ENDS users should use the products with caution until more comprehensive studies are performed. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.
Authors: Maciej L Goniewicz; Ribhav Gupta; Yong Hee Lee; Skyler Reinhardt; Sungroul Kim; Bokyeong Kim; Leon Kosmider; Andrzej Sobczak Journal: Int J Drug Policy Date: 2015-02-07
Authors: Aylin Kalayciyan; Helmut Orawa; Sabine Fimmel; Frank H Perschel; José-B González; Rudolf G Fitzner; Constantin E Orfanos; Christos C Zouboulis Journal: J Invest Dermatol Date: 2006-09-28 Impact factor: 8.551
Authors: Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz Journal: Tob Control Date: 2013-03-06 Impact factor: 7.552
Authors: Chad A Lerner; Isaac K Sundar; Hongwei Yao; Janice Gerloff; Deborah J Ossip; Scott McIntosh; Risa Robinson; Irfan Rahman Journal: PLoS One Date: 2015-02-06 Impact factor: 3.240
Authors: Stefanie Scheffler; Hauke Dieken; Olaf Krischenowski; Christine Förster; Detlev Branscheid; Michaela Aufderheide Journal: Int J Environ Res Public Health Date: 2015-04-08 Impact factor: 3.390
Authors: Peyton A Tierney; Clarissa D Karpinski; Jessica E Brown; Wentai Luo; James F Pankow Journal: Tob Control Date: 2015-04-15 Impact factor: 7.552
Authors: Stefanie Scheffler; Hauke Dieken; Olaf Krischenowski; Michaela Aufderheide Journal: Int J Environ Res Public Health Date: 2015-10-05 Impact factor: 3.390
Authors: Alexsandra Ratajczak; Wojciech Feleszko; Danielle M Smith; Maciej Goniewicz Journal: Expert Rev Respir Med Date: 2018-06-08 Impact factor: 3.772
Authors: Amy L Nyman; Kymberle L Sterling; Ban A Majeed; Dina M Jones; Michael P Eriksen Journal: Nicotine Tob Res Date: 2018-08-14 Impact factor: 4.244
Authors: Claire E Otero; Jacob A Noeker; Mary M Brown; Florence D M Wavreil; Wendy A Harvey; Kristen A Mitchell; Sara J Heggland Journal: J Appl Toxicol Date: 2019-01-28 Impact factor: 3.446
Authors: Tatiana Basáñez; Anuja Majmundar; Tess Boley Cruz; Jon-Patrick Allem; Jennifer B Unger Journal: Am J Public Health Date: 2019-02 Impact factor: 9.308
Authors: Alexandra Noël; Christina M Verret; Farhana Hasan; Slawomir Lomnicki; John Morse; Annette Robichaud; Arthur L Penn Journal: J Vis Exp Date: 2018-08-25 Impact factor: 1.355
Authors: Dongmei Li; Isaac K Sundar; Scott McIntosh; Deborah J Ossip; Maciej Lukasz Goniewicz; Richard J O'Connor; Irfan Rahman Journal: Tob Control Date: 2019-02-13 Impact factor: 7.552